Akcea Initiates AKCEA-ANGPTL3-LRx Phase 2 Program in Patients with Rare Hyperlipidemias
Nov 13, 2017 21:15 pm UTC| Business
CAMBRIDGE, Mass., Nov. 13, 2017 -- Akcea Therapeutics, Inc. (NASDAQ:AKCA), an affiliate of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS), focused on developing and commercializing drugs to treat patients with serious...
Precipio, Inc. Announces Closing of $2,748,000 Registered Direct Offering
Nov 13, 2017 21:15 pm UTC| Business
NEW HAVEN, Conn., Nov. 13, 2017 -- Precipio, Inc. (NASDAQ:PRPO), announced today that it has completed a registered direct offering for the purchase and sale of 2,748 units, each consisting of one share of Series C...
Meta Financial Group, Inc.® Announces Shelly Schneekloth as Head of Tech & Ops
Nov 13, 2017 21:15 pm UTC| Business
SIOUX FALLS, S.D., Nov. 13, 2017 -- Meta Financial Group, Inc.® (Nasdaq:CASH) (“Meta” or the “Company”) announced today that Shelly Schneekloth has joined the Company as Executive Vice President and Head of Technology...
James River Group Holdings Announces Closing of Secondary Offering
Nov 13, 2017 21:15 pm UTC| Business
PEMBROKE, Bermuda, Nov. 13, 2017 -- James River Group Holdings, Ltd. (NASDAQ:JRVR) (“James River” or the “Company”) announced today the closing of the previously announced underwritten secondary public offering of the...
Acura Pharmaceuticals Announces Third Quarter 2017 Financial Results
Nov 13, 2017 21:15 pm UTC| Business
PALATINE, Ill., Nov. 13, 2017 -- Acura Pharmaceuticals, Inc. (OTCQB:ACUR), a specialty pharmaceutical company innovating abuse deterrent drugs, announced today financial results for the three and nine months ended...
Schmitt Industries, Inc. Announces Record Date for Its Rights Offering to Shareholders
Nov 13, 2017 21:10 pm UTC| Business
PORTLAND, Ore., Nov. 13, 2017 -- Schmitt Industries, Inc. (NASDAQ:SMIT) (the “Company”) today announced that the record date for its previously announced rights offering will be November 27, 2017. The net proceeds...
POET Technologies Reports Third Quarter 2017 Financial Results
Nov 13, 2017 21:10 pm UTC| Business
SAN JOSE, Calif., Nov. 13, 2017 -- POET Technologies Inc. (the “Company” or “POET”) (OTCQX:POETF) (TSX Venture:PTK), a developer and manufacturer of optical light source products for the sensing and data communications...
FDA Approval of Opdivo Injection Sparks Hope for Cancer Patients with Revolutionary Treatment Update